Back to Search
RITA AXELROD, M.D.
M.D.
Medical Oncology Physician
NPI: 1881616126Individual
Specialties, Licenses & Credentials
Research & Publications (14)
Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group.
PMID 19634157·Cancer·2009
3-trial
Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.
PMID 19043526·Transl Oncol·2008
8-other
A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study.
PMID 18296423·Ann Oncol·2008
3-trial
Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2.
PMID 18281658·J Clin Oncol·2008
3-trial
Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx cancer.
PMID 17765768·Otolaryngol Head Neck Surg·2007
8-other
Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
PMID 17075122·J Clin Oncol·2006
3-trial
Evolution of contingent altruism when cooperation is expensive.
PMID 16427106·Theor Popul Biol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 925 CHESTNUT ST, SUITE 320A
PHILADELPHIA, PA 19107 - Phone
- (215) 955-8874
Quick Facts
- NPI
- 1881616126
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile